Prediction of clinically significant prostate cancer using radiomics models in real-world clinical practice: a retrospective multicenter study.

"Declarations Ethics approval and consent to participateEthics committee approval was granted by the local institutional ethics review board, and the requirement of written informed consent was waived. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Consent for publicationNot applicable. Competing interestsThe author (Y.S.) from a commercial company, Siemens Healthineers Ltd., was an MR collaboration scientist doing technical support in this study under Siemens collaboration regulation without any payment or personal concern regarding this study. All other authors of this manuscript declare no relationships with any tissues. Competing interests The author (Y.S.) from a commercial company, Siemens Healthineers Ltd., was an MR collaboration scientist doing technical support in this study under Siemens collaboration regulation without any payment or personal concern regarding this study. All other authors of this manuscript declare no relationships with any tissues."

"Funding 1. Contract grant sponsor: The Suzhou Science and Technology Development Plan Project; contract grant number: KJXW2023006 (to J.B.). 2. Contract grant sponsor: Natural Science Foundation of Boxi Incubation Program of the First AffIliated hospital of Soochow University; contract grant number: BXQN2023029 (to J.B.) 3. Contract grant sponsor: Gusu health talent project of Suzhou; contract grant number: GSWS2020003 (to H.C.H.)"